Works by Osa, Akio

Results: 8

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41051-2

By:

Iwahori, Kota;
Nii, Takuro;
Yamaguchi, Norihiko;
Kawasaki, Takahiro;
Okamura, Satomi;
Hashimoto, Kazuki;
Matsuki, Takanori;
Tsujino, Kazuyuki;
Miki, Keisuke;
Osa, Akio;
Goya, Sho;
Abe, Kinya;
Mori, Masahide;
Takeda, Yoshito;
Yamada, Tomomi;
Kida, Hiroshi;
Kumanogoh, Atsushi

Publication type:

Article

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41051-2

By:

Iwahori, Kota;
Nii, Takuro;
Yamaguchi, Norihiko;
Kawasaki, Takahiro;
Okamura, Satomi;
Hashimoto, Kazuki;
Matsuki, Takanori;
Tsujino, Kazuyuki;
Miki, Keisuke;
Osa, Akio;
Goya, Sho;
Abe, Kinya;
Mori, Masahide;
Takeda, Yoshito;
Yamada, Tomomi;
Kida, Hiroshi;
Kumanogoh, Atsushi

Publication type:

Article

Tubular nephrotoxicity induced by docetaxel in non-small-cell lung cancer patients.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 4, p. 395, doi. 10.1007/s10147-011-0304-5

By:

Takimoto, Takayuki;
Nakabori, Tasuku;
Osa, Akio;
Morita, Satomu;
Terada, Haruko;
Oseto, Susumu;
Iwazawa, Takashi;
Abe, Kinya

Publication type:

Article

Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 2, p. 155, doi. 10.1007/s10147-011-0256-9

By:

Tetsumoto, Satoshi;
Osa, Akio;
Kijima, Takashi;
Minami, Toshiyuki;
Hirata, Haruhiko;
Takahashi, Ryo;
Kuhara, Hanako;
Nagatomo, Izumi;
Takeda, Yoshito;
Kida, Hiroshi;
Goya, Sho;
Tachibana, Isao;
Kawase, Ichiro

Publication type:

Article

Stratification of Malignant Pleural Mesothelioma Prognosis Using Recursive Partitioning Analysis.

Published in:

Lung (0341-2040), 2014, v. 192, n. 1, p. 191, doi. 10.1007/s00408-013-9516-y

By:

Suzuki, Hidekazu;
Asami, Kazuhiro;
Hirashima, Tomonori;
Okamoto, Norio;
Yamadori, Tadahiro;
Tamiya, Motohiro;
Morishita, Naoko;
Shiroyama, Takayuki;
Takeoka, Sawa;
Osa, Akio;
Azuma, Yuichiro;
Okishio, Kyoichi;
Kawaguchi, Tomoya;
Atagi, Shinji;
Kawase, Ichiro

Publication type:

Article

Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis.

Published in:

Thoracic Cancer, 2019, v. 10, n. 11, p. 2183, doi. 10.1111/1759-7714.13197

By:

Osa, Akio;
Uenami, Takeshi;
Naito, Yujiro;
Hirata, Haruhiko;
Koyama, Shohei;
Takimoto, Takayuki;
Shiroyama, Takayuki;
Futami, Shinji;
Nakatsubo, Saeko;
Sawa, Nobuhiko;
Yano, Yukihiro;
Nagatomo, Izumi;
Takeda, Yoshito;
Mori, Masahide;
Kida, Hiroshi;
Kumanogoh, Atsushi

Publication type:

Article

Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03583-4

By:

Matsumoto, Kinnosuke;
Shiroyama, Takayuki;
Tamiya, Motohiro;
Minami, Toshiyuki;
Kinehara, Yuhei;
Tamiya, Akihiro;
Suga, Yasuhiko;
Kuge, Tomoki;
Mori, Masahide;
Suzuki, Hidekazu;
Tobita, Satoshi;
Ueno, Kiyonobu;
Namba, Yoshinobu;
Tetsumoto, Satoshi;
Niki, Toshie;
Morimura, Osamu;
Osa, Akio;
Nishino, Kazumi;
Nagatomo, Izumi;
Takeda, Yoshito

Publication type:

Article

Relationship between progression-free survival and overall survival in patients with advanced non-small cell lung cancer treated with anticancer agents after first-line treatment failure.

Published in:

Asia Pacific Journal of Clinical Oncology, 2015, v. 11, n. 2, p. 121, doi. 10.1111/ajco.12199

By:

Suzuki, Hidekazu;
Hirashima, Tomonori;
Okamoto, Norio;
Yamadori, Tadahiro;
Tamiya, Motohiro;
Morishita, Naoko;
Shiroyama, Takayuki;
Takeoka, Sawa;
Osa, Akio;
Azuma, Yuichiro;
Kawase, Ichiro

Publication type:

Article